Active Ingredient(s): Duvelisib
FDA Approved: * September 24, 2018
Pharm Company: * VERASTEM INC
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Copiktra Overview

Duvelisib, sold under the brand name Copiktra, is a medication used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and follicular lymphoma after other treatments have failed.[3] It is taken by mouth.[3] Common side effects include diarrhea, low white blood cells, rash, feeling tired, fever, and muscle pains.[3] Other serious side effects include inflammation of the lungs and infections.[3] It is a ...

Read more Copiktra Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Copiktra Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Capsule: 15mg, 25mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Copiktra: (2 results)

Sorted by National Drug Code
  • 71779-115 Copiktra 15 mg Oral Capsule by Verastem, Inc.
  • 71779-125 Copiktra 25 mg Oral Capsule by Verastem, Inc.

Other drugs which contain Duvelisib or a similar ingredient: (1 result)